Европска Унија - Енглески - EMA (European Medicines Agency)

insmed netherlands b.v. - amikacin sulfate - respiratory tract infections - antibacterials for systemic use, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Индија - Енглески - Central Drugs Standard Control Organization

cadila oncocare - leprosy immunomodulator - v - mycobacterium heat killed 0.5 * 10-9,thiomersal 0.1%w/v,nacl 0.9%w/v - 0.5ml

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

prionics ag - mycobacterium bovis purified protein derivatives (ppd) - diagnostic agents - animal - diagnostic agent | allergy screen test | intradermal test | johne's diseases diagnosis | tuberculin test | tuberculosis detection

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

prionics ag - mycobacterium bovis purified protein derivatives (ppd) - diagnostic agents - animal - diagnostic agent | allergy screen test | intradermal test | johne's diseases diagnosis | tuberculin test | tuberculosis detection

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioniche animal health (a/asia) pty. ltd. - mycobacterium cell wall fraction - immunotherapy - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - equine respiratory tract infections vira | infections of viral origin

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetsearch international pty ltd - mycobacterium cell wall fraction - immunotherapy - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - not applicable (vet)

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

csl limited - mycobacterium tuberculosis bcg strain 805 - immunotherapy - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - vaccines and antisera | brown snake bite | cheesy gland | enterotoxaemia | tetanus

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

prionics ag - mycobacterium avium purified protein derivative (ppd) - diagnostic agents - cattle | pigs | poultry | beef | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bull | bullock | calf - diagnostic agent | allergy screen test | intradermal test | johne's diseases diagnosis | tuberculin test | tuberculosis detection

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

apotex nz ltd - azithromycin dihydrate 261.02mg equivalent to 250 mg azithromycin - film coated tablet - 250 mg - active: azithromycin dihydrate 261.02mg equivalent to 250 mg azithromycin excipient: calcium hydrogen phosphate dihydrate croscarmellose sodium hyprolose magnesium stearate opadry white 31k58875 purified water - azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. chlamydia trachomatis conjunctivitis and trachoma. 5. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. azithromycin is indicated for use in children for the treatment of the following infections: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. 5. acute streptococcal pharyngitis/tonsillitis. 6. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. the 20 mg/kg azithromycin dose appears to be as effective as penicillin in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 7. chlamydia trachomatis conjunctivitis and trachoma in children 12 months or older.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

apotex nz ltd - azithromycin dihydrate 522.04mg equivalent to 500 mg azithromycin - film coated tablet - 500 mg - active: azithromycin dihydrate 522.04mg equivalent to 500 mg azithromycin excipient: calcium hydrogen phosphate dihydrate croscarmellose sodium hyprolose magnesium stearate opadry white 31k58875 purified water - azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. chlamydia trachomatis conjunctivitis and trachoma. 5. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. azithromycin is indicated for use in children for the treatment of the following infections: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. 5. acute streptococcal pharyngitis/tonsillitis. 6. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. the 20 mg/kg azithromycin dose appears to be as effective as penicillin in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 7. chlamydia trachomatis conjunctivitis and trachoma in children 12 months or older.